Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GDNF: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | GDNF |
| Aliases | Glial Cell Line-Derived Neurotrophic Factor |
| Chromosome | 5q32 |
| Protein Family | GDNF family (TGF-β superfamily) |
| Function | Maintains tyrosine hydroxylase expression |
| Primary Expression | Secreted, Extracellular space |
| Subcellular Localization | Secreted, Extracellular space |
| Molecular Weight | 15 kDa |
| Pathways | PI3K, MAPK, TGF-β |
| UniProt ID | P39905 |
| GeneCards | GDNF |
| Human Protein Atlas | GDNF |
| GFRα1 | Co-receptor essential for GDNF signaling specificity |
| RET | Receptor tyrosine kinase required for GDNF-mediated activation |
| Neurturin | GDNF family member with overlapping but distinct biological roles |
| Associated Diseases | ALS, APOPTOSIS, Alzheimer, Amyotrophic Lateral Sclerosis, Anxiety |
| Known Drugs/Compounds | levodopa, trehalose, rapamycin |
| Interactions | GFRAL, BDNF, GLP1R, SHH, ADCY3, LMX1A |
| SciDEX Hypotheses | GDNF Gradient Establishment by Schwann Cells Enabl |
| KG Connections | 779 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
GDNF["GDNF"] -.->|"inhibits"| Dopamine["Dopamine"]
GDNF["GDNF"] -->|"activates"| Dopamine["Dopamine"]
GDNF["GDNF"] -->|"interacts with"| Dopamine["Dopamine"]
GDNF["GDNF"] -->|"therapeutic target"| Dopamine["Dopamine"]
Dopamine["Dopamine"] -->|"interacts with"| GDNF["GDNF"]
GDNF["GDNF"] -.->|"inhibits"| Als["Als"]
GDNF["GDNF"] -->|"activates"| Als["Als"]
GDNF["GDNF"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
GDNF["GDNF"] -->|"associated with"| TNF["TNF"]
GDNF["GDNF"] -->|"associated with"| MITOCHONDRIA["MITOCHONDRIA"]
GDNF["GDNF"] -->|"associated with"| TAU["TAU"]
GDNF["GDNF"] -->|"associated with"| GFAP["GFAP"]
style GDNF fill:#4a1a6b,stroke:#333,color:#e0e0e0
style Dopamine fill:#006494,stroke:#333,color:#e0e0e0
style Als fill:#ef5350,stroke:#333,color:#e0e0e0
style NEURODEGENERATION fill:#006494,stroke:#333,color:#e0e0e0
style TNF fill:#4a1a6b,stroke:#333,color:#e0e0e0
style MITOCHONDRIA fill:#4a1a6b,stroke:#333,color:#e0e0e0
style TAU fill:#4a1a6b,stroke:#333,color:#e0e0e0
style GFAP fill:#4a1a6b,stroke:#333,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Neural Stem Cell Differentiation | regulates | process | 0.90 |
| neurons | expressed_in | cell_type | 0.90 |
| neurotrophin signaling | participates_in | pathway | 0.85 |
| PARKINSON'S DISEASE | treats | disease | 0.85 |
| astrocytes | expressed_in | cell_type | 0.85 |
| RET | activates | gene | 0.80 |
| brain health | promotes | biological_process | 0.80 |
| neurons | activates | cell_type | 0.80 |
| neurons | protects_against | cell_type | 0.80 |
| neurons | associated_with | cell_type | 0.80 |
| Parkinson's disease | activates | disease | 0.80 |
| NEURODEGENERATION | protects_against | disease | 0.75 |
| IL-10 | activates | gene | 0.75 |
| unfolded protein response | participates_in | pathway | 0.75 |
| TGF-beta signaling | participates_in | pathway | 0.75 |
| Dopamine | inhibits | entity | 0.70 |
| Dopamine | activates | entity | 0.70 |
| Dopamine | interacts_with | entity | 0.70 |
| Dopamine | therapeutic_target | entity | 0.70 |
| neurodegeneration | interacts_with | disease | 0.70 |
| HDAC1 | inhibits | gene | 0.70 |
| brainstem | expressed_in | brain_region | 0.70 |
| RET | regulates | gene | 0.70 |
| neurodegeneration | regulates | disease | 0.70 |
| GFRA1 | interacts_with | gene | 0.70 |
| NGF | regulates | gene | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| BRAINSTEM | activates | brain_region | 0.70 |
| BRAINSTEM | treats | brain_region | 0.70 |
| neural stem cells | activates | cell_type | 0.70 |
| dopaminergic neurons | protects_against | cell_type | 0.70 |
| neurons | regulates | cell_type | 0.70 |
| T cells | expressed_in | cell_type | 0.70 |
| TNF | associated_with | gene | 0.65 |
| TAU | associated_with | gene | 0.65 |
| GFAP | associated_with | gene | 0.65 |
| NGF | associated_with | gene | 0.65 |
| neuroinflammation | activates | disease | 0.65 |
| HSP70 | protects_against | gene | 0.65 |
| astrocyte | co_discussed | concept | 0.65 |
| neuroinflammation | co_discussed | concept | 0.65 |
| PI3K | co_discussed | gene | 0.65 |
| TREM2 | co_discussed | gene | 0.65 |
| STAT3 | co_discussed | gene | 0.65 |
| autophagy | co_discussed | concept | 0.65 |
| AKT | protects_against | gene | 0.65 |
| Als | inhibits | disease | 0.65 |
| Als | activates | disease | 0.65 |
| NEURODEGENERATION | associated_with | concept | 0.65 |
| MITOCHONDRIA | associated_with | gene | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| PARKINSON'S DISEASE | associated_with | disease | 0.96 |
| h-47ab2be5 | targets_gene | hypothesis | 0.90 |
| BDNF | protects_against | gene | 0.85 |
| AAV | transports | drug | 0.85 |
| BDNF | associated_with | gene | 0.82 |
| AMYLOID | associated_with | gene | 0.82 |
| GLP-1 | upregulates | protein | 0.80 |
| Multiplexed Base Editing | activates | mechanism | 0.80 |
| Dopamine | interacts_with | entity | 0.70 |
| BDNF | expressed_in | gene | 0.70 |
| TREHALOSE | protects_against | drug | 0.70 |
| TREHALOSE | destabilizes | drug | 0.70 |
| ASTROCYTE | protects_against | cell_type | 0.70 |
| BDNF | inhibits | gene | 0.66 |
| BDNF | activates | gene | 0.66 |
| ALS | associated_with | gene | 0.66 |
| APOPTOSIS | associated_with | gene | 0.66 |
| AQP4 | associated_with | gene | 0.65 |
| CNTF | associated_with | gene | 0.65 |
| APP | associated_with | gene | 0.65 |
| AKT | co_discussed | gene | 0.65 |
| HEDGEHOG SIGNALING | protects_against | pathway | 0.65 |
| AUTOPHAGY | associated_with | gene | 0.65 |
| ASTROCYTE | associated_with | gene | 0.65 |
| AMPK | associated_with | gene | 0.65 |
| INFLAMMATION | regulates | phenotype | 0.65 |
| NEURONS | treats | cell_type | 0.65 |
| rapamycin | targets | drug | 0.65 |
| STRIATUM | activates | brain_region | 0.65 |
| ERK | activates | gene | 0.65 |
| MICROGLIA | regulates | cell_type | 0.65 |
| GLP1R | inhibits | gene | 0.60 |
| GFRAL | inhibits | gene | 0.60 |
| APP | inhibits | gene | 0.60 |
| HDAC6 | activates | gene | 0.60 |
| RET | regulates | gene | 0.60 |
| GFRAL | activates | gene | 0.60 |
| OVERVIEW | therapeutic_target | gene | 0.60 |
| BDNF | therapeutic_target | gene | 0.60 |
| VIMENTIN | expressed_in | gene | 0.60 |
| NGF | activates | gene | 0.60 |
| UBIQUITIN | inhibits | gene | 0.60 |
| ASCL1 | activates | gene | 0.60 |
| BDNF | contributes_to | gene | 0.60 |
| NGF | contributes_to | gene | 0.60 |
| NGF | associated_with | gene | 0.60 |
| TLR4 | activates | gene | 0.60 |
| NLRP3 | inhibits | gene | 0.60 |
| OVERVIEW | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| GDNF Gradient Establishment by Schwann Cells Enables Motor R | 0.585 | neurodegeneration | What molecular mechanisms enable functio |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.658
neurodegeneration | 2026-04-04 | 9 hypotheses Top: 0.670
neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.622
neurodegeneration | 2026-04-01 | 6 hypotheses Top: 0.469
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.570
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||